Performance of the American Heart Association/American College of Cardiology/Heart Rhythm Society versus European Society of Cardiology guideline criteria for hospital admission of patients with syncope.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 2022
Historique:
received: 17 12 2021
revised: 28 04 2022
accepted: 23 05 2022
pubmed: 2 6 2022
medline: 5 10 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Current American College of Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA/HRS) and European Society of Cardiology (ESC) guidelines recommend different strategies to avoid low-yield admissions in patients with syncope. The purpose of this study was to directly compare the safety and efficacy of applying admission criteria of both guidelines to patients presenting with syncope to the emergency department in 2 multicenter studies. The international BASEL IX (BAsel Syncope EvaLuation) study (median age 71 years) and the U.S. SRS (Improving Syncope Risk Stratification in Older Adults) study (median age 72 years) were investigated. Primary endpoints were sensitivity/specificity for the adjudicated diagnosis of cardiac syncope (BASEL IX only) and 30-day major adverse cardiovascular events (30d-MACE). Among 2560 patients in the BASEL IX and 2085 in SRS studies, ACC/AHA/HRS and ESC criteria recommended admission for a comparable number of patients in BASEL IX (27% vs 28%), but ACC/AHA/HRS criteria less often in SRS (19% vs 32%; P <.01). Recommendations were discordant in ∼25% of patients. In BASEL IX, sensitivity for cardiac syncope and 30d-MACE among patients without admission criteria was comparable for ACC/AHA/HRS and ESC criteria (64% vs 65%, P = .86; and 67% vs 71%, P = .15, respectively). In SRS, sensitivity for 30d-MACE was lower with ACC/AHA/HRS (54%) vs ESC criteria (88%; P <.001). Similarly, specificity for cardiac syncope and 30d-MACE in BASEL IX was comparable for both guidelines, but in SRS the ACC/AHA/HRS guidelines showed a higher specificity for 30d-MACE than the ESC guidelines. ACC/AHA/HRS and ESC guidelines showed disagreement regarding admission for 1 in 4 patients and had only modest sensitivity, all indicating possible opportunities for improvements.

Sections du résumé

BACKGROUND
Current American College of Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA/HRS) and European Society of Cardiology (ESC) guidelines recommend different strategies to avoid low-yield admissions in patients with syncope.
OBJECTIVE
The purpose of this study was to directly compare the safety and efficacy of applying admission criteria of both guidelines to patients presenting with syncope to the emergency department in 2 multicenter studies.
METHODS
The international BASEL IX (BAsel Syncope EvaLuation) study (median age 71 years) and the U.S. SRS (Improving Syncope Risk Stratification in Older Adults) study (median age 72 years) were investigated. Primary endpoints were sensitivity/specificity for the adjudicated diagnosis of cardiac syncope (BASEL IX only) and 30-day major adverse cardiovascular events (30d-MACE).
RESULTS
Among 2560 patients in the BASEL IX and 2085 in SRS studies, ACC/AHA/HRS and ESC criteria recommended admission for a comparable number of patients in BASEL IX (27% vs 28%), but ACC/AHA/HRS criteria less often in SRS (19% vs 32%; P <.01). Recommendations were discordant in ∼25% of patients. In BASEL IX, sensitivity for cardiac syncope and 30d-MACE among patients without admission criteria was comparable for ACC/AHA/HRS and ESC criteria (64% vs 65%, P = .86; and 67% vs 71%, P = .15, respectively). In SRS, sensitivity for 30d-MACE was lower with ACC/AHA/HRS (54%) vs ESC criteria (88%; P <.001). Similarly, specificity for cardiac syncope and 30d-MACE in BASEL IX was comparable for both guidelines, but in SRS the ACC/AHA/HRS guidelines showed a higher specificity for 30d-MACE than the ESC guidelines.
CONCLUSION
ACC/AHA/HRS and ESC guidelines showed disagreement regarding admission for 1 in 4 patients and had only modest sensitivity, all indicating possible opportunities for improvements.

Identifiants

pubmed: 35644354
pii: S1547-5271(22)02038-0
doi: 10.1016/j.hrthm.2022.05.024
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1712-1722

Investigateurs

Velina Widmer (V)
Kathrin Leu (K)
Tobias Reichlin (T)
Samyut Shrestha (S)
Michael Freese (M)
Philipp Krisai (P)
Maria Belkin (M)
Damian Kawecki (D)
Beata Morawiec (B)
Piotr Muzyk (P)
Ewa Nowalany-Kozielska (E)
Nicolas Geigy (N)
Gemma Martinez-Nadal (G)
Carolina Isabel Fuenzalida Inostroza (CI)
José Bustamante Mandrión (JB)
Imke Poepping (I)
Jaimi Greenslade (J)
Tracey Hawkins (T)
Katharina Rentsch (K)
Sandra Mitrovic (S)
Arnold von Eckardstein (A)
Andreas Buser (A)
Stefan Osswald (S)
Joan Walter (J)
David H Adler (DH)
Aveh Bastani (A)
Christopher W Baugh (CW)
Jeffrey M Caterino (JM)
Deborah B Diercks (DB)
Judd E Hollander (JE)
Bret A Nicks (BA)
Daniel K Nishijima (DK)
Manish N Shah (MN)
Kirk A Stiffler (KA)
Scott T Wilber (ST)
Alan B Storrow (AB)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Jeanne du Fay de Lavallaz (J)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network. Electronic address: jeanne.dufay@usb.ch.

Tobias Zimmermann (T)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Patrick Badertscher (P)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Pedro Lopez-Ayala (P)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Thomas Nestelberger (T)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network; Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Òscar Miró (Ò)

GREAT Network; Hospital Clinic, Barcelona, Catalonia, Spain.

Emilio Salgado (E)

GREAT Network; Hospital Clinic, Barcelona, Catalonia, Spain.

Xenia Zaytseva (X)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; University Hospital Zürich, Zürich, Switzerland.

Michele Sara Gafner (MS)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Michael Christ (M)

Department of Emergency Medicine, Kantonsspital Luzern, Lucerne, Switzerland.

Louise Cullen (L)

GREAT Network; Royal Brisbane & Women's Hospital, Herston, Australia.

Martin Than (M)

GREAT Network; Christchurch Hospital, Christchurch, New Zealand.

F Javier Martin-Sanchez (FJ)

GREAT Network; Servicio de Urgencias, Hospital Clínico San Carlos, Madrid, Spain.

Salvatore Di Somma (S)

GREAT Network; Emergency Medicine, Department of Medical-Surgery Sciences and Translational Medicine, University Sapienza Rome, Sant'Andrea Hospital, Rome, Italy.

W Frank Peacock (WF)

GREAT Network; Department of Emergency Medicine, Baylor College of Medicine, Houston, Texas.

Dagmar I Keller (DI)

University Hospital Zürich, Zürich, Switzerland.

Juan Pablo Costabel (JP)

Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Alan Sigal (A)

Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Christian Puelacher (C)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Desiree Wussler (D)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Luca Koechlin (L)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network; Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.

Ivo Strebel (I)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Sereina Schuler (S)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; University Hospital Zürich, Zürich, Switzerland.

Robert Manka (R)

University Hospital Zürich, Zürich, Switzerland.

Murat Bilici (M)

Department of Orthopedics and Traumatology, Basel University Hospital, Basel, Switzerland.

Jens Lohrmann (J)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Michael Kühne (M)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Tobias Breidthardt (T)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Carol L Clark (CL)

Beaumont Health System-Royal Oak, Royal Oak, Michigan.

Marc Probst (M)

Department of Emergency Medicine, Mount Sinai School of Medicine, New York, New York.

Thomas A Gibson (TA)

Department of Biostatistics, University of California Fielding School of Public Health, Los Angeles, California.

Robert E Weiss (RE)

Department of Biostatistics, University of California Fielding School of Public Health, Los Angeles, California.

Benjamin C Sun (BC)

Department of Emergency Medicine, Leonard David Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania.

Christian Mueller (C)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH